EXECUTED


 


FOURTH AMENDMENT TO PLASMA
PURCHASE AGREEMENT


 


This Fourth
Amendment to the Plasma Purchase Agreement (this “Amendment #4”) by and between Biotest Pharmaceuticals Corporation,
a Delaware corporation having a place of business at 5800 Park of Commerce Boulevard, NW, Boca Raton, Florida 33487(“BPC”)
and ADMA Biologics, Inc., a Delaware corporation having a place of business at 465 Route 17 South, Ramsey, New Jersey 07446
(“ADMA”) is effective as of June 6, 2017 (the “ Effective Date”).


 


WHEREAS,
BPC and ADMA are parties to that certain Plasma Purchase Agreement, effective as of November 17, 2011 (as amended, restated, supplemented
or otherwise modified from time to time,, the “Agreement”), pursuant to which ADMA purchases from BPC source
plasma containing antibodies to respiratory syncytial virus;


 


WHEREAS,
BPC and ADMA are parties to that certain Master Purchase and Sale Agreement (as amended, restated, supplemented or otherwise modified
from time to time), dated as of January 21, 2017; and


 


WHEREAS,
BPC and ADMA desire to further amend the Agreement in order to memorialize the modification of certain provisions.


 


NOW, THEREFORE,
in consideration of the respective promises contained herein and other valuable consideration, the receipt and legal sufficiency
of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows:


 


Amendment:


 


		1.	The Initial Term, as that term is defined in the Agreement,
is hereby extended such that it will continue for a period of ten (10) years from the Effective Date.



 


Miscellaneous:


 


Except as
expressly provided herein, all terms and conditions set forth in the Agreement remain unchanged and continue in full force and
effect. This Amendment #4 shall govern in the event of any conflict between this Amendment #4 and the Agreement. It is agreed by
the parties that all references to the Agreement hereafter made by them in any document or instrument delivered pursuant to or
in connection with the Agreement shall be deemed to refer to the Agreement as amended hereby.


 


This Amendment
#4 and the Agreement embody the entire agreement and understanding between the parties hereto with respect to the subject matter
hereof and supersede all prior agreements and understandings relating to the subject matter hereof.


 


This Amendment
#4 may be executed in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute
one and the same single document, and any such counterpart containing an electronically scanned or facsimile signature will have
the same effect as original manual signatures.


 


The parties
agree that they and their employees shall execute all documents and do all other things necessary to carry out the intent to implement
the provisions of this Amendment #4.


 






    Page 1 of 1


    


    

 


 


IN
WITNESS WHEREOF, the parties hereby have caused this Amendment #4 to be executed and the persons signing below warrant that
they are duly authorized to sign for and on behalf of their respective parties.


 





	ADMA Biologics, Inc.

                            

                           By: /s/ Adam Grossman

                           Name: Adam Grossman

                           Title: President and Chief Executive Officer 
	 



 


[Signature page to 4th Amendment
to RSV Plasma Purchase Agreement]


 






    


    


    

 


IN WITNESS WHEREOF, the parties
hereby have caused this Amendment
#4 to be executed
and the persons signing
below warrant that they are duly authorized to
sign for and on behalf
of their respective parties.


 


	Biotest Pharmaceuticals Corporation

                            

                           By: /s/ Ileana Carlisle

                           Name: Ileana Carlisle

                           Title: Chief Exective Officer 
	 



 


[Signature page to
4th Amendment to RSV Plasma Purchase
Agreement]